These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11251379

  • 1. Improving DNA vaccines targeting viral infection.
    Sin JI, Weiner DB.
    Intervirology; 2000; 43(4-6):233-46. PubMed ID: 11251379
    [Abstract] [Full Text] [Related]

  • 2. Update on antiviral DNA vaccine research (1998-2000).
    Schultz J, Dollenmaier G, Mölling K.
    Intervirology; 2000; 43(4-6):197-217. PubMed ID: 11251376
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC, Anderson E, Bootland LM, Chiou PW, Johnson M, Kim C, Mourich D, Trobridge G.
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthetic DNA vaccine strategies against persistent viral infections.
    Villarreal DO, Talbott KT, Choo DK, Shedlock DJ, Weiner DB.
    Expert Rev Vaccines; 2013 May; 12(5):537-54. PubMed ID: 23659301
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccines: developing new strategies to enhance immune responses.
    Abdulhaqq SA, Weiner DB.
    Immunol Res; 2008 May; 42(1-3):219-32. PubMed ID: 19066740
    [Abstract] [Full Text] [Related]

  • 9. Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice.
    Li X, Cao H, Wang Q, Di B, Wang M, Lu J, Pan L, Yang L, Mei M, Pan X, Li G, Wang L.
    Microbes Infect; 2012 Sep; 14(11):1000-7. PubMed ID: 22626929
    [Abstract] [Full Text] [Related]

  • 10. Recombinant viruses as vaccines against viral diseases.
    Souza AP, Haut L, Reyes-Sandoval A, Pinto AR.
    Braz J Med Biol Res; 2005 Apr; 38(4):509-22. PubMed ID: 15962176
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccines for biodefence.
    Garmory HS, Perkins SD, Phillpotts RJ, Titball RW.
    Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1343-61. PubMed ID: 15935877
    [Abstract] [Full Text] [Related]

  • 12. DNA Vaccines - A Modern Gimmick or a Boon to Vaccinology?
    Manickan E, Karem KL, Rouse BT.
    Crit Rev Immunol; 2017 Jun 17; 37(2-6):483-498. PubMed ID: 29773031
    [Abstract] [Full Text] [Related]

  • 13. DNA vaccines for viral diseases.
    Davis HL, McCluskie MJ.
    Microbes Infect; 1999 Jan 17; 1(1):7-21. PubMed ID: 10594972
    [Abstract] [Full Text] [Related]

  • 14. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE, Zhang J, Whitton JL.
    Virology; 1999 Oct 10; 263(1):175-83. PubMed ID: 10544092
    [Abstract] [Full Text] [Related]

  • 15. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
    Hung CF, Yang M, Wu TC.
    Methods Mol Med; 2006 Oct 10; 127():199-220. PubMed ID: 16988456
    [Abstract] [Full Text] [Related]

  • 16. Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects.
    Zhang E, Kosinska AD, Ma Z, Dietze KK, Xu Y, Meng Z, Zhang X, Wang J, Wang B, Dittmer U, Roggendorf M, Yang D, Lu M.
    Virology; 2015 Jan 15; 475():56-65. PubMed ID: 25462346
    [Abstract] [Full Text] [Related]

  • 17. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.
    Virus Res; 2006 Mar 15; 116(1-2):11-20. PubMed ID: 16214252
    [Abstract] [Full Text] [Related]

  • 18. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
    Fleeton MN, Liljeström P, Sheahan BJ, Atkins GJ.
    J Gen Virol; 2000 Mar 15; 81(Pt 3):749-58. PubMed ID: 10675413
    [Abstract] [Full Text] [Related]

  • 19. DNA vaccination against La Crosse virus.
    Pavlovic J, Schultz J, Hefti HP, Schuh T, Mölling K.
    Intervirology; 2000 Mar 15; 43(4-6):312-21. PubMed ID: 11251387
    [Abstract] [Full Text] [Related]

  • 20. Current developments in viral DNA vaccines: shall they solve the unsolved?
    Rajcáni J, Mosko T, Rezuchová I.
    Rev Med Virol; 2005 Mar 15; 15(5):303-25. PubMed ID: 15906276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.